BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 23225413)

  • 1. Toxicity of magnetic albumin microspheres bearing adriamycin.
    Ma J; Chen D; Tian Y; Tao K
    J Tongji Med Univ; 2000; 20(3):261-2. PubMed ID: 11215066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
    Colombo PE; Boustta M; Poujol S; Pinguet F; Rouanet P; Bressolle F; Vert M
    Eur J Pharm Sci; 2007 May; 31(1):43-52. PubMed ID: 17383164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model.
    Namur J; Wassef M; Millot JM; Lewis AL; Manfait M; Laurent A
    J Vasc Interv Radiol; 2010 Feb; 21(2):259-67. PubMed ID: 20123210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis.
    Sugarbaker PH; Van der Speeten K; Anthony Stuart O; Chang D
    Eur J Surg Oncol; 2011 Aug; 37(8):719-26. PubMed ID: 21621952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.
    Hong K; Khwaja A; Liapi E; Torbenson MS; Georgiades CS; Geschwind JF
    Clin Cancer Res; 2006 Apr; 12(8):2563-7. PubMed ID: 16638866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin -eluting beads in the treatment of liver carcinoma.
    Vogl TJ; Lee C
    Expert Opin Pharmacother; 2014 Jan; 15(1):115-20. PubMed ID: 24215628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy.
    Sugarbaker PH
    Int J Hyperthermia; 2007 Aug; 23(5):431-42. PubMed ID: 17701534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.
    Binder S; Lewis AL; Löhr JM; Keese M
    World J Gastroenterol; 2013 Nov; 19(43):7586-93. PubMed ID: 24282349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal use of doxorubicin drug-eluting beads in sheep: a pilot safety study.
    Binder S; Lewis AL; Jesenofsky R; Neumaier M; Jäger E; Ströbel P; Löhr JM; Keese M
    Anticancer Res; 2012 Dec; 32(12):5167-74. PubMed ID: 23225413
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.